MK-0217-908

· Organon and Co

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0217-908, covering 2022-02-02 to 2022-02-02. Get the full timeline:

Most recent: Clinical Trial Update: Study of Investigational Drug in Osteoporosis (MK-0217-908) [Phase 3]